EuropeBiocidal Products Regulation (BPR)

Spain Drafts New Royal Decree To Update Biocides Registration And Use Rules

Spain has circulated a draft Royal Decree to modernise national biocides rules, update registers and training requirements, and align procedures with the EU Biocidal Products Regulation.

Dr Steven Brennan

2 min readAI-drafted, expert reviewed

Compliance desk with biocides documentation and controlled storage

Spain has published a draft Royal Decree intended to modernise its national framework for biocides, updating how products are registered, how establishments and service providers are overseen, and how staff competency requirements are managed in practice.

The draft is framed as a complementary national layer to the EU Biocidal Products Regulation (Regulation (EU) No 528/2012). While the EU regulation applies directly, Spain’s draft explains that legacy national rules remain relevant for questions such as the division of responsibilities between state and regional authorities, national registers and certain operational controls.

What The Draft Covers

The proposal sets out conditions for authorisation, manufacture, packaging, storage, commercialisation and use of biocides in Spain. It also provides for a national, public Official Register of Biocides in which authorised products are to be recorded, and it ties registration obligations to whether active substances are on the EU list of approved substances for the relevant product type or remain in the EU review programme.

Communications relating to registration are described as being handled through the ECHA “Register for Biocidal Products” (R4BP) platform for the relevant biocides, reflecting the operational reality that many regulatory exchanges for biocides are routed via EU-level tools.

Competent Authorities And Market Controls

The draft allocates roles across multiple bodies. It describes responsibilities for the Ministry of Health, including authorisation and register management, while recognising input from other ministries and national bodies for areas such as environmental protection and animal health. It also sets out enforcement expectations for Spain’s autonomous communities and the cities of Ceuta and Melilla, including market surveillance and sanctioning powers within their territories.

On the operational side, the draft includes detailed conditions for manufacturing and storage. It describes expectations for secure and suitable storage areas, separation from food and feed, and access controls. It also prohibits storing biocides in homes and other inappropriate locations, reflecting a focus on preventing misuse and reducing exposure risks.

Questions about this change

What does the Spanish draft Royal Decree aim to update?

The draft sets out national rules complementing the EU Biocidal Products Regulation, including conditions for authorisation, manufacture, packaging, storage, commercialisation and use of biocides in Spain. It also addresses the national Official Register of Biocides, the Register of Establishments and Biocidal Services (ROESB), training requirements for biocide treatments, and an updated approach to infringements and sanctions.

What practical compliance areas could be affected for companies placing biocides on the Spanish market?

Companies should expect closer alignment to EU submission workflows, including use of ECHA’s R4BP platform for communications, and clearer expectations on registration and market oversight. Operationally, the draft includes detailed requirements for storage and sale, such as separation from food and feed, controlled access for certain products, and traceability expectations, all of which can affect distributors, service providers and industrial users.

Dr Steven Brennan

CEO and co-founder of Foresight, and a co-opted member of ECHA's Committee for Socio-economic Analysis. He holds a PhD in chemical engineering.

More from Dr Steven Brennan

Join 3,500+ professionals staying ahead

Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.

Free. Unsubscribe at any time.

Read by professionals at

  • Boeing
  • AstraZeneca
  • Siemens
  • PepsiCo
  • SpaceX